Oncozenge AB (ONCOZ) — Capital Reinvestment Ratio

Latest as of September 2021: 108.17x

Oncozenge AB (ONCOZ) has a Capital Reinvestment Ratio of 108.17x as of September 2021, meaning it reinvests 108% of its operating cash flow (Skr12.00K) in capital expenditures (Skr1.30 Million). See Oncozenge AB balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

108.17x

Capex / Operating Cash Flow

Operating Cash Flow

Skr12.00K

SEK

Capital Expenditures

Skr1.30 Million

SEK

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Oncozenge AB (None–None)

Year-by-year Capital Reinvestment Ratio for Oncozenge AB from None to None. For live market cap and broader valuation context, see ONCOZ market cap.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow